Everything we do starts with our Mission: to enable our customers to make the world healthier, cleaner and safer.
Read MoreEverything we do starts with our Mission: to enable our customers to make the world healthier, cleaner and safer.
Read MoreEverything we do starts with our Mission: to enable our customers to make the world healthier, cleaner and safer.
Read MoreEverything we do starts with our Mission: to enable our customers to make the world healthier, cleaner and safer.
Read MoreDESPITE decades of research, many fundamental questions about Alzheimer’s disease remain unanswered, including how the disease begins and progresses across different regions of the brain. Researchers are working to uncover those answers by looking more closely at the proteins involved in disease progression, where they are located and how they change over time.
In this video, Dr. Jun Qu, Ph.D., professor, Department of Pharmaceutical Sciences, University at Buffalo, explains how advances in spatial proteomics and mass spectrometry are helping researchers map proteins with greater precision and identify early signals associated with Alzheimer’s disease.
By discovering new potential biomarkers and therapeutic targets, this research could help enable earlier detection, more effective treatments and a more precise approach to understanding and managing the disease.
Watch other videos in this series